{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:36:45Z","timestamp":1789763805528,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5349-2","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T06:03:19Z","timestamp":1550124199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-5360","authenticated-orcid":false,"given":"Omar F.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soundouss","family":"Raissouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mica","family":"Pabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Haeseker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny J.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"5349_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21387\n                    \n                  .","journal-title":"CA Cancer J Clin"},{"key":"5349_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/07357900801905519","volume":"26","author":"MT Halpern","year":"2008","unstructured":"Halpern MT, Yabroff KR. Prevalence of outpatient cancer treatment in the United States: estimates from the medical panel expenditures survey (MEPS). Cancer Investig. 2008;26:647\u201351.","journal-title":"Cancer Investig"},{"key":"5349_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11912-013-0307-7","volume":"15","author":"E O\u2019Farrell","year":"2013","unstructured":"O\u2019Farrell E, MacKenzie J, Collins B. Clearing the air: a review of our current understanding of \u201cchemo fog\u201d. Curr Oncol Rep. 2013;15:260\u20139.","journal-title":"Curr Oncol Rep"},{"key":"5349_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","volume":"12","author":"JS Wefel","year":"2012","unstructured":"Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12:267\u201375.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"5349_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/pon.3163","volume":"22","author":"B Collins","year":"2013","unstructured":"Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology. 2013;22:1517\u201327.","journal-title":"Psychooncology"},{"key":"5349_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/cncr.20272","volume":"100","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292\u20139.","journal-title":"Cancer"},{"key":"5349_CR7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/cncr.22610","volume":"109","author":"K Hermelink","year":"2007","unstructured":"Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer. 2007;109:1905\u201313.","journal-title":"Cancer"},{"key":"5349_CR8","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/cncr.23853","volume":"113","author":"K Hermelink","year":"2008","unstructured":"Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer. 2008;113:2431\u20139.","journal-title":"Cancer"},{"key":"5349_CR9","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1200\/JCO.2009.27.0827","volume":"28","author":"TA Ahles","year":"2010","unstructured":"Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010;28:4434\u201340.","journal-title":"J Clin Oncol"},{"key":"5349_CR10","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00520-010-0997-4","volume":"19","author":"CE Jansen","year":"2011","unstructured":"Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer. 2011;19:1647\u201356.","journal-title":"Support Care Cancer"},{"key":"5349_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/07347330903183117","volume":"27","author":"SA Reid-Arndt","year":"2009","unstructured":"Reid-Arndt SA, Yee A, Perry MC, Hsieh C. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol. 2009;27:415\u201334.","journal-title":"J Psychosoc Oncol"},{"key":"5349_CR12","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1002\/cncr.25098","volume":"116","author":"JS Wefel","year":"2010","unstructured":"Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116:3348\u201356.","journal-title":"Cancer"},{"key":"5349_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/clpt.2011.112","volume":"90","author":"JE Fardell","year":"2011","unstructured":"Fardell JE, Vardy J, Johnston IN, Winocur G. Chemotherapy and cognitive impairment: treatment options. Clin Pharmacol Ther. 2011;90:366\u201376.","journal-title":"Clin Pharmacol Ther"},{"key":"5349_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","volume":"39","author":"KD Hodgson","year":"2013","unstructured":"Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39:297\u2013304.","journal-title":"Cancer Treat Rev"},{"key":"5349_CR15","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","volume":"88","author":"VT Chang","year":"2000","unstructured":"Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton symptom assessment scale. Cancer. 2000;88:2164\u201371 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10813730\n                    \n                  . Accessed 23 Jul 2017.","journal-title":"Cancer"},{"key":"5349_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","volume":"10","author":"E Hoddes","year":"1973","unstructured":"Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431\u20136.","journal-title":"Psychophysiology"},{"key":"5349_CR17","unstructured":"Cancer Institute N. Common Terminology Criteria for Adverse Events v4.0 (CTCAE). 2009. \n                    https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf\n                    \n                  . Accessed 8 Sep 2017."},{"key":"5349_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/001872088202400409","volume":"24","author":"RT Wilkinson","year":"1982","unstructured":"Wilkinson RT, Houghton D. Field test of arousal: a portable reaction timer with data storage. Hum Factors. 1982;24:487\u201393.","journal-title":"Hum Factors"},{"key":"5349_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/sleep\/34.5.581","volume":"34","author":"M Basner","year":"2011","unstructured":"Basner M, Dinges DF. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep. 2011;34:581\u201391.","journal-title":"Sleep"},{"key":"5349_CR20","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1080\/07420520601067931","volume":"23","author":"GD Roach","year":"2006","unstructured":"Roach GD, Dawson D, Lamond N. Can a shorter psychomotor vigilance task be used as a reasonable substitute for the ten-minute psychomotor vigilance task? Chronobiol Int. 2006;23:1379\u201387.","journal-title":"Chronobiol Int"},{"key":"5349_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1037\/a0018883","volume":"136","author":"J Lim","year":"2010","unstructured":"Lim J, Dinges DF. A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychol Bull. 2010;136:375\u201389.","journal-title":"Psychol Bull"},{"key":"5349_CR22","first-page":"1059","volume":"28","author":"SP Drummond","year":"2005","unstructured":"Drummond SP, Bischoff-Grethe A, Dinges DF, Ayalon L, Mednick SC, Meloy MJ. The neural basis of the psychomotor vigilance task. Sleep. 2005;28:1059\u201368.","journal-title":"Sleep"},{"key":"5349_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.aap.2007.07.008","volume":"40","author":"SD Baulk","year":"2008","unstructured":"Baulk SD, Biggs SN, Reid KJ, van den Heuvel CJ, Dawson D. Chasing the silver bullet: measuring driver fatigue using simple and complex tasks. Accid Anal Prev. 2008;40:396\u2013402.","journal-title":"Accid Anal Prev"},{"key":"5349_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/07420520601085925","volume":"23","author":"RM Petrilli","year":"2006","unstructured":"Petrilli RM, Roach GD, Dawson D, Lamond N. The sleep, subjective fatigue, and sustained attention of commercial airline pilots during an international pattern. Chronobiol Int. 2006;23:1357\u201362.","journal-title":"Chronobiol Int"},{"key":"5349_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jama.294.9.1025","volume":"294","author":"JT Arnedt","year":"2005","unstructured":"Arnedt JT, Owens J, Crouch M, Stahl J, Carskadon MA. Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion. JAMA. 2005;294:1025\u201333.","journal-title":"JAMA"},{"key":"5349_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4300\/JGME-D-12-00324.1","volume":"5","author":"J McDonald","year":"2013","unstructured":"McDonald J, Potyk D, Fischer D, Parmenter B, Lillis T, Tompkins L, et al. Napping on the night shift: a study of sleep, performance, and learning in physicians-in-training. J Grad Med Educ. 2013;5:634\u20138.","journal-title":"J Grad Med Educ"},{"key":"5349_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/13803395.2012.762340","volume":"35","author":"KL Sinclair","year":"2013","unstructured":"Sinclair KL, Ponsford JL, Rajaratnam SM, Anderson C. Sustained attention following traumatic brain injury: use of the psychomotor vigilance task. J Clin Exp Neuropsychol. 2013;35:210\u201324.","journal-title":"J Clin Exp Neuropsychol"},{"key":"5349_CR28","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1378\/chest.11-2214","volume":"141","author":"C Lal","year":"2012","unstructured":"Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012;141:1601\u201310.","journal-title":"Chest"},{"key":"5349_CR29","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/j.1476-5381.2011.01689.x","volume":"165","author":"S Bodenmann","year":"2012","unstructured":"Bodenmann S, Hohoff C, Freitag C, Deckert J, Retey JV, Bachmann V, et al. Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation. Br J Pharmacol. 2012;165:1904\u201313.","journal-title":"Br J Pharmacol"},{"key":"5349_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/thoraxjnl-2013-203796","volume":"69","author":"JL Chapman","year":"2014","unstructured":"Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, et al. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Thorax. 2014;69:274\u20139.","journal-title":"Thorax"},{"key":"5349_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00213-012-2869-8","volume":"225","author":"SJ Crowley","year":"2013","unstructured":"Crowley SJ, Eastman CI. Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance. Psychopharmacology. 2013;225:825\u201337.","journal-title":"Psychopharmacology"},{"key":"5349_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/00140130310001617930","volume":"47","author":"N Lamond","year":"2004","unstructured":"Lamond N, Dorrian J, Burgess H, Holmes A, Roach G, McCulloch K, et al. Adaptation of performance during a week of simulated night work. Ergonomics. 2004;47:154\u201365.","journal-title":"Ergonomics"},{"key":"5349_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3758\/BF03195580","volume":"36","author":"S Loh","year":"2004","unstructured":"Loh S, Lamond N, Dorrian J, Roach G, Dawson D. The validity of psychomotor vigilance tasks of less than 10-minute duration. Behav Res Methods Instrum Comput. 2004;36:339\u201346.","journal-title":"Behav Res Methods Instrum Comput"},{"key":"5349_CR34","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/nprot.2006.390","volume":"1","author":"CR Bowie","year":"2006","unstructured":"Bowie CR, Harvey PD. Administration and interpretation of the trail making test. Nat Protoc. 2006;1:2277\u201381.","journal-title":"Nat Protoc"},{"key":"5349_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1207\/S15324826AN0902_5","volume":"9","author":"KB Kortte","year":"2002","unstructured":"Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol. 2002;9:106\u20139.","journal-title":"Appl Neuropsychol"},{"key":"5349_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/13803395.2010.541228","volume":"33","author":"JJ O\u2019Rourke","year":"2011","unstructured":"O\u2019Rourke JJ, Beglinger LJ, Smith MM, Mills J, Moser DJ, Rowe KC, et al. The trail making test in prodromal Huntington disease: contributions of disease progression to test performance. J Clin Exp Neuropsychol. 2011;33:567\u201379.","journal-title":"J Clin Exp Neuropsychol"},{"key":"5349_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2466\/pms.110.2.429-441","volume":"110","author":"AL Schmitt","year":"2010","unstructured":"Schmitt AL, Livingston RB, Smernoff EN, Waits BL, Harris JB, Davis KM. Dichotomous scoring of trails B in patients referred for a dementia evaluation. Percept Mot Skills. 2010;110:429\u201341.","journal-title":"Percept Mot Skills"},{"key":"5349_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1745-6215-14-187","volume":"14","author":"N Galiano-Castillo","year":"2013","unstructured":"Galiano-Castillo N, Ariza-Garcia A, Cantarero-Villanueva I, Fernandez-Lao C, Diaz-Rodriguez L, Legeren-Alvarez M, et al. Telehealth system (e-CUIDATE) to improve quality of life in breast cancer survivors: rationale and study protocol for a randomized clinical trial. Trials. 2013;14:187.","journal-title":"Trials"},{"key":"5349_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.15288\/jsad.2013.74.635","volume":"74","author":"AM Day","year":"2013","unstructured":"Day AM, Celio MA, Lisman SA, Johansen GE, Spear LP. Acute and chronic effects of alcohol on trail making test performance among underage drinkers in a field setting. J Stud Alcohol Drugs. 2013;74:635\u201341.","journal-title":"J Stud Alcohol Drugs"},{"key":"5349_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/arclin\/acr024","volume":"26","author":"S Wagner","year":"2011","unstructured":"Wagner S, Helmreich I, Dahmen N, Lieb K, Tadic A. Reliability of three alternate forms of the trail making tests a and B. Arch Clin Neuropsychol. 2011;26:314\u201321.","journal-title":"Arch Clin Neuropsychol"},{"key":"5349_CR41","doi-asserted-by":"crossref","unstructured":"Jongen S, Vuurman E, Ramaekers J, Vermeeren A. Alcohol calibration of tests measuring skills related to car driving. Psychopharmacology. 2014.","DOI":"10.1007\/s00213-013-3408-y"},{"key":"5349_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.sleep.2010.03.015","volume":"11","author":"US Herrmann","year":"2010","unstructured":"Herrmann US, Hess CW, Guggisberg AG, Roth C, Gugger M, Mathis J. Sleepiness is not always perceived before falling asleep in healthy, sleep-deprived subjects. Sleep Med. 2010;11:747\u201351. \n                    https:\/\/doi.org\/10.1016\/j.sleep.2010.03.015\n                    \n                  .","journal-title":"Sleep Med"},{"key":"5349_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1518\/001872099779577336","volume":"41","author":"SH Fairclough","year":"1999","unstructured":"Fairclough SH, Graham R. Impairment of driving performance caused by sleep deprivation or alcohol: a comparative study. Hum Factors J Hum Factors Ergon Soc. 1999;41:118\u201328. \n                    https:\/\/doi.org\/10.1518\/001872099779577336\n                    \n                  .","journal-title":"Hum Factors J Hum Factors Ergon Soc"},{"key":"5349_CR44","unstructured":"Canadian Medical Association. CMA Driver's Guide: Determining medical fitness to operate motor vehicles. 8th ed. Canadian Medical Association: 2012. \n                    https:\/\/www.cma.ca\/secure\/assets\/assets-library\/document\/en\/CMA-Drivers-Guide-8th-edition-e.pdf\n                    \n                  . Accessed 23 Jul 2017."},{"key":"5349_CR45","unstructured":"United Kingdom Driver and Vehicle Licensing Agency. Assessing fitness to drive - a guide for medical professionals. 2017. \n                    https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/618072\/assessing-fitness-to-drive-a-guide-for-medical-professionals.pdf\n                    \n                  . Accessed 23 Jul 2017."},{"key":"5349_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5014\/ajot.2013.007823","volume":"67","author":"AE Dickerson","year":"2013","unstructured":"Dickerson AE. Driving assessment tools used by driver rehabilitation specialists: survey of use and implications for practice. Am J Occup Ther. 2013;67:564\u201373. \n                    https:\/\/doi.org\/10.5014\/ajot.2013.007823\n                    \n                  .","journal-title":"Am J Occup Ther"},{"key":"5349_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/187152810792231887","volume":"9","author":"E Syrigou","year":"2010","unstructured":"Syrigou E, Triantafyllou O, Makrilia N, Kaklamanos I, Kotanidou A, Manolopoulos L, et al. Acute hypersensitivity reactions to chemotherapy agents: an overview. Inflamm Allergy Drug Targets. 2010;9:206\u201313 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20632960\n                    \n                  . Accessed 23 Jul 2017.","journal-title":"Inflamm Allergy Drug Targets"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5349-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5349-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5349-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:09:18Z","timestamp":1581620958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5349-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5349"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5349-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the Health Research Ethics Board of Alberta Cancer Committee (reference number HREBA.CC-16-0840). Informed consent was obtained in writing from each participant, and all participants in the study provided consent independently (in no cases was consent provided by a family member or surrogate decision maker in place of the participant). The consent process and assessment of decision making capacity of patients was performed in accordance with the Canadian Tri-Council Policy Statement 2, available at \/), as well as the Guideline for Good Clinical Practice. Adherence to the criteria laid out in both of these documents have been approved by the ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no conflicts of interest or competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"150"}}